HF
ETON icon

HRT Financial’s Eton Pharmaceutcials ETON Stock Holding History

HRT Financial’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-57,235
Closed -$742K – 2882
2025
Q1 		$742K Buy
+57,235
New +$865K ﹤0.01% 1272
2021
Q4 		– Sell
-39,012
Closed -$196K – 3416
2021
Q3 		$196K Sell
39,012
-11,057
-22% -$57.5K ﹤0.01% 2697
2021
Q2 		$308K Buy
+50,069
New +$371K ﹤0.01% 2123

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

HRT Financial's ETON Position: Q2 2025 in Review

HRT Financial sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 57,235 shares — an estimated $742K sold.

HRT Financial first reported a position in ETON in Q2 2021 and held it in 3 quarters. The position peaked at $742K in Q1 2025. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • HRT Financial reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 57,235 Eton Pharmaceutcials shares in Q2 2025, an estimated $742K.
  • HRT Financial first reported a position in Eton Pharmaceutcials in Q2 2021 and held it in 3 quarters.
  • HRT Financial's Eton Pharmaceutcials position peaked at $742K in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.